Current symptoms: Even minor or transient nausea, vomiting, stomach pains, cramping, indigestion, gas, bloating, or reflux
Together, they prove that GLP-1 therapy can induce a state of "metabolic neuropathy" even in patients with normal blood sugar
The study also showed that semaglutide lowered the risk of major heart problems, like heart attack or worsening heart failure, by 20% in people without diabetes who had cardiovascular disease, overweight, or obesity
However, it is important to note that further research and high-quality clinical trials are needed to establish the true efficacy of natural GLP-1 inducers and to determine if their effectiveness is comparable to that of GLP-1 drugs
Overexpression of erythrocyte glutathione S-transferase in uremia and dialysis [PMID: 10508125] Laboratory literature summary: Overexpression of erythrocyte glutathione S-transferase in uremia and dialysis
& Ghervan, C